Clinical Trial Update: Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating azathioprine metabolite concentrations and cytokine levels in neuromyelitis optica spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Azathioprine (azathioprine)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: NMO Spectrum Disorder, Azathioprine Adverse Reaction | Phase 4 | Status: COMPLETED